Article
Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives
1 Jul 2017
Abstract excerpt
Abstract: ROS1 rearrangement characterizes a small subset (1%–2%) of non-small cell lung cancer and is associated with slight/never smoking patients and adenocarcinoma histology. Identification of ROS1 rearrangement is mandatory to permit targeted therapy with specific inhibitors, demonstrating a significantly better survival when compared with conventional chemotherapy. Detection of ROS1 rearrangement is based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
